Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers

Front Immunol. 2021 Feb 22:11:630139. doi: 10.3389/fimmu.2020.630139. eCollection 2020.

Abstract

Extrahepatic cancers of the biliary system are typically asymptomatic until after metastasis, which contributes to their poor prognosis. Here we examined intrahepatic cholangiocarcinomas (n = 8), carcinomas of perihilar bile ducts (n = 7), carcinomas of the gallbladder (n = 11) and hepatic metastasis from carcinomas of the gallbladder (n = 4) for the expression of the extracellular matrix glycoproteins tenascin-C and tenascin-W. Anti-tenascin-C and anti-tenascin-W immunoreactivity was found in all biliary tract tumors examined. Unlike tenascin-C, tenascin-W was not detected in normal hepatobiliary tissue. Tenascin-W was also expressed by the cholangiocarcinoma-derived cell line Huh-28. However, co-culture of Huh-28 cells with immortalized bone marrow-derived stromal cells was necessary for the formation and organization of tenascin-W fibrils in vitro. Our results indicate that tenascin-W may be a novel marker of hepatobiliary tumor stroma, and its absence from many normal tissues suggests that it may be a potential target for biotherapies.

Keywords: extracellular matrix; gallbladder cancer; tenascin-C; tenascin-N; tenascin-W; tumor stroma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biliary Tract Neoplasms / immunology*
  • Biliary Tract Neoplasms / pathology
  • Biomarkers, Tumor / immunology*
  • Cell Line, Tumor
  • Humans
  • Neoplasm Proteins / immunology*
  • Stromal Cells / immunology
  • Stromal Cells / pathology
  • Tenascin / immunology*

Substances

  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Tenascin
  • tenascin-W, human